The bacterial strain involved is resistant to standard antibiotic treatments<\/p>\n<\/h3>\n
By Deanna Neff HealthDay Reporter<\/b>
\n<\/b><\/p>\n
THURSDAY, Feb. 19, 2026 (HealthDay News) \u2014 It’s often touted as the “miracle tree” for its dense nutrient profile, but a popular moringa supplement is at the center of a superbug outbreak.<\/p>\n
Federal health officials announced<\/a> Feb. 13 that a multistate outbreak of highly drug-resistant Salmonella<\/em> has been traced back to moringa powder capsules.<\/p>\n The investigation, conducted by the U.S. Food and Drug Administration (FDA) and the U.S. Centers for Disease Control and Prevention (CDC), has identified seven infections across seven states: Washington, Arizona, Iowa, Illinois, Indiana, Tennessee and Florida.<\/p>\n What makes this outbreak particularly concerning is the nature of the bacteria. Testing showed this Salmonella<\/em> strain is drug resistant, meaning it does not respond to any of the antibiotics typically used to treat these infections.<\/p>\n While many Salmonella<\/em> cases resolve on their own, drug-resistant versions are much harder to manage if the infection spreads to the bloodstream. Of the seven reported cases, three individuals have required hospitalization. No deaths have been reported.<\/p>\n In response to the findings, Ambrosia Brands, LLC has initiated a voluntary recall of specific lots of its Rosabella-brand moringa powder capsules.<\/p>\n Recalled lot numbers and product images can be found on the FDA alert<\/a>.<\/p>\n The products were primarily sold through the company\u2019s website. Notably, the company stated that no affected lots were sold through its official Amazon store, though it warned that unauthorized third-party sellers on sites like eBay or Shein may have distributed the product.<\/p>\n The recall affects 60-count bottles with expiration dates between March and November 2027.<\/p>\n “We have discontinued use and purchase of all raw moringa leaf powder from the raw material supplier” of the affected lots, the company stated in an official release<\/a>.<\/p>\n Consumers who have taken the supplement should watch for signs of <\/a>Salmonella<\/a><\/em> poisoning<\/a>, which typically include fever, diarrhea and stomach cramps.<\/p>\n Because this strain is resistant to common medicines, anyone experiencing severe symptoms should inform their health care provider about any exposure to the recalled moringa capsules.<\/p>\n Consumers with questions may contact the company weekdays from 9 a.m. to 4 p.m. CT at 914-768-1357.<\/p>\n More information<\/strong><\/p>\n The U.S. Centers for Disease Control and Prevention (CDC) has more about Salmonella <\/a><\/em>symptoms and outbreak tracking<\/a>.<\/p>\n SOURCES: FOX Business, Feb. 17, 2026; U.S. Food and Drug Administration, recall notice, Feb. 13, 2026<\/p>\n